| Phase I (PH I) Mad Refractory Solid Tumor Study (NCT00099606) | Bristol-Myers Squibb | 2004-07-01 |
| Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) (NCT00087451) | Merck Sharp & Dohme LLC | 2004-07-01 |
| The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity (NCT00530101) | University of Miami | 2004-07-01 |
| A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated (NCT00233506) | University of Iowa | 2004-07-01 |
| Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients (NCT00160992) | University of Lausanne Hospitals | 2004-07-01 |
| Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma (NCT00091104) | National Institutes of Health Clinical Center (CC) | 2004-07-01 |
| Treatment Targets for Chronic Hypertension in Pregnancy (NCT00194974) | Weill Medical College of Cornell University | 2004-07-01 |
| Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia (NCT00243399) | Children's Hospital Medical Center, Cincinnati | 2004-07-01 |
| Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma (NCT00161590) | Weill Medical College of Cornell University | 2004-07-01 |
| Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis (NCT00570349) | Mallinckrodt | 2004-07-01 |
| Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression (NCT00090506) | National Center for Complementary and Integrative Health (NCCIH) | 2004-07-01 |
| Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients (NCT00207233) | Boston Medical Center | 2004-07-01 |
| Partial Breast Irradiation With Chemotherapy (NCT00278109) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-07-01 |
| Clinical Trials of Regeneration for Periodontal Tissue (NCT00221130) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2004-07-01 |
| A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata (NCT01069094) | Repros Therapeutics Inc. | 2004-07-01 |
| The Active by Choice Today (ACT) Trial to Increase Physical Activity (NCT01028144) | University of South Carolina | 2004-07-01 |
| Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fasting Conditions (NCT01131728) | Dr. Reddy's Laboratories Limited | 2004-07-01 |
| AZD5438 in Patients With Advanced Solid Malignancies (NCT00088790) | AstraZeneca | 2004-07-01 |
| The Effects of Testosterone on Prostate Tissue (ACYP-1) (NCT00161486) | University of Washington | 2004-07-01 |
| Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents (NCT00102479) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-07-01 |
| Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control (NCT00460499) | American Heart Association | 2004-07-01 |
| Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting Conditions (NCT01161927) | Dr. Reddy's Laboratories Limited | 2004-07-01 |
| Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00089362) | National Cancer Institute (NCI) | 2004-07-01 |
| Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms (NCT00243893) | University of California, San Francisco | 2004-07-01 |
| Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients (NCT00204607) | University Hospital Tuebingen | 2004-07-01 |
| Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis (NCT00103974) | Bayhill Therapeutics | 2004-07-01 |
| Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II) (NCT00409981) | University Hospital, Saarland | 2004-07-01 |
| The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma (NCT00459069) | Beth Israel Deaconess Medical Center | 2004-07-01 |
| Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112 (NCT00088517) | National Institute of Mental Health (NIMH) | 2004-07-01 |
| Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia (NCT00086099) | MedImmune LLC | 2004-07-01 |
| GW572016 In Patients With Advanced Or Metastatic Breast Cancer (NCT00462956) | GlaxoSmithKline | 2004-06-30 |
| Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer (NCT00359190) | GlaxoSmithKline | 2004-06-29 |
| Experimental Vaccine for Plasmodium Falciparum Malaria (NCT00340431) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-06-09 |
| Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer (NCT00096304) | Medical University of South Carolina | 2004-06-08 |
| A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants (NCT05999942) | Insmed Incorporated | 2004-06-02 |
| Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation (NCT00167661) | University of Wisconsin, Madison | 2004-06-01 |
| Hydralazine as Demethylating Agent in Breast Cancer (NCT00575978) | University of Arkansas | 2004-06-01 |
| A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers (NCT00863590) | Merck Sharp & Dohme LLC | 2004-06-01 |
| Study of CellCept for Advanced Pancreatic Cancer (NCT00997958) | Columbia University | 2004-06-01 |
| Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors (NCT00086528) | Kadmon Corporation, LLC | 2004-06-01 |
| Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia (NCT00067405) | National Center for Complementary and Integrative Health (NCCIH) | 2004-06-01 |
| A Study of ARRY-142886 in Patients With Advanced Cancer (NCT00085787) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2004-06-01 |
| 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting (NCT00834587) | Teva Pharmaceuticals USA | 2004-06-01 |
| Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib (NCT00820417) | Harrison Clinical Research | 2004-06-01 |
| The ENTERPRISE Study - Study of the Enterprise Self-Expanding Stent System (NCT00288405) | Codman & Shurtleff | 2004-06-01 |
| Hypofractionated Radiotherapy for Lung Cancer (NCT00214123) | University of Wisconsin, Madison | 2004-06-01 |
| Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets (NCT01179646) | Kremers Urban Development Company | 2004-06-01 |
| Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions (NCT00803764) | Perrigo Company | 2004-06-01 |
| Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes (NCT00093366) | Fred Hutchinson Cancer Center | 2004-06-01 |
| Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1 (NCT00100113) | National Institute on Drug Abuse (NIDA) | 2004-06-01 |
| A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions (NCT00863941) | Actavis Inc. | 2004-06-01 |
| Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma (NCT00350961) | Rigshospitalet, Denmark | 2004-06-01 |
| Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma (NCT00384553) | University of Magdeburg | 2004-06-01 |
| Assessment of Interactions Between Methamphetamine and Aripiprazole - 1 (NCT00089440) | National Institute on Drug Abuse (NIDA) | 2004-06-01 |
| A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer (NCT01187485) | University of Chicago | 2004-06-01 |
| Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer (NCT00088933) | National Cancer Institute (NCI) | 2004-06-01 |
| Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis (NCT00244153) | Charite University, Berlin, Germany | 2004-06-01 |
| Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin (NCT02170844) | Boehringer Ingelheim | 2004-06-01 |
| Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions (NCT00803192) | Perrigo Company | 2004-06-01 |
| Fasted Bioavailability Study of Cilostazol Tablets, 50mg (NCT00685802) | Mutual Pharmaceutical Company, Inc. | 2004-06-01 |
| Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children (NCT00927134) | University of Zurich | 2004-06-01 |
| Antihyperlipidemic Effects of Oyster Mushrooms (NCT00069524) | National Center for Complementary and Integrative Health (NCCIH) | 2004-06-01 |
| Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma (NCT00182650) | City of Hope Medical Center | 2004-06-01 |
| Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma (NCT00084747) | Jonsson Comprehensive Cancer Center | 2004-06-01 |
| Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer (NCT00463840) | NYU Langone Health | 2004-06-01 |
| Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer (NCT00170625) | North Eastern German Society of Gynaecological Oncology | 2004-06-01 |
| Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00079430) | National Cancer Institute (NCI) | 2004-06-01 |
| Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease (NCT00384306) | GlaxoSmithKline | 2004-06-01 |
| CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease (NCT00087789) | Sangamo Therapeutics | 2004-06-01 |
| Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors (NCT00086970) | National Cancer Institute (NCI) | 2004-06-01 |
| Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions (NCT00804401) | Perrigo Company | 2004-06-01 |
| Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions (NCT00829712) | Teva Pharmaceuticals USA | 2004-06-01 |
| Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions (NCT00802828) | Perrigo Company | 2004-06-01 |
| 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma (NCT00088868) | National Institutes of Health Clinical Center (CC) | 2004-06-01 |
| Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions (NCT00829673) | Teva Pharmaceuticals USA | 2004-06-01 |
| Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL (NCT00274742) | Amgen Research (Munich) GmbH | 2004-06-01 |
| Preventing HIV/Aids in Drug Abusing Youth (NCT00680719) | Oregon Research Institute | 2004-06-01 |
| Developing Violence Prevention Therapy for Substance Abusers (NCT00551863) | University of Michigan | 2004-06-01 |
| Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers (NCT02260050) | Boehringer Ingelheim | 2004-06-01 |
| A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors (NCT00276913) | Synta Pharmaceuticals Corp. | 2004-06-01 |
| A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer (NCT00226941) | George Albert Fisher | 2004-06-01 |
| Bion for Occipital Nerve Stimulation (NCT00205829) | Boston Scientific Corporation | 2004-06-01 |
| Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome (NCT00593658) | University of Alabama at Birmingham | 2004-06-01 |
| Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma (NCT00193258) | SCRI Development Innovations, LLC | 2004-06-01 |
| Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (NCT00151216) | Weill Medical College of Cornell University | 2004-06-01 |
| Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects (NCT01796938) | UCB BIOSCIENCES GmbH | 2004-06-01 |
| Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers. (NCT00211627) | Miller, Chipp St. Kevin, M.D. | 2004-06-01 |
| Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106) (NCT00972595) | Merck Sharp & Dohme LLC | 2004-06-01 |
| CD133+ Autologous Cells After Myocardial Infarction (NCT00400959) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2004-06-01 |
| SB-715992 In Combination With Docetaxel In Patients With Solid Tumors (NCT00169520) | GlaxoSmithKline | 2004-06-01 |
| Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer (NCT00242190) | University of Michigan Rogel Cancer Center | 2004-06-01 |
| Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer (NCT00217529) | Fred Hutchinson Cancer Center | 2004-06-01 |
| To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions (NCT00881400) | Sandoz | 2004-06-01 |
| Telephone Assessment and Skill-Building Kit (TASK): A New Program for Family Caregivers of Stroke Survivors (NCT00264745) | Indiana University | 2004-06-01 |
| Minocycline and Perfusion Pressure Augmentation in Acute Spinal Cord Injury (NCT00559494) | University of Calgary | 2004-06-01 |
| Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation (NCT00185757) | Stanford University | 2004-06-01 |
| Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia (NCT00485810) | Eli Lilly and Company | 2004-06-01 |
| Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma (NCT00600002) | Edward Nelson | 2004-06-01 |
| Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1 (NCT00106158) | Ludwig Institute for Cancer Research | 2004-06-01 |
| Dose Response to Recombinant Factor VIIa When Administered for Bleed (NCT00104455) | Novo Nordisk A/S | 2004-06-01 |